CLINICAL TRIALS PROFILE FOR DEXEDRINE

All Clinical Trials for DEXEDRINE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00296686 ↗	Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression	Terminated	New York State Psychiatric Institute	Phase 4	2001-09-01	This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.
NCT00363298 ↗	Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD	Completed	Obsessive Compulsive Foundation	N/A	2006-08-01	The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks.
NCT00363298 ↗	Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD	Completed	Stanford University	N/A	2006-08-01	The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks.
NCT00439049 ↗	Substance Abuse Pre-Treatment Screening Study	Recruiting	National Institute on Drug Abuse (NIDA)		2005-10-01	The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
NCT00439049 ↗	Substance Abuse Pre-Treatment Screening Study	Recruiting	The University of Texas Health Science Center, Houston		2005-10-01	The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.

Clinical Trial Conditions for DEXEDRINE

Condition Name

Condition Name for DEXEDRINE
Intervention	Trials
Attention Deficit Hyperactivity Disorder	4
Attention Deficit Hyperactivity Disorder (ADHD)	2
Alcohol Dependence	1
Major Depression	1

Condition MeSH

Condition MeSH for DEXEDRINE
Intervention	Trials
Attention Deficit Disorder with Hyperactivity	7
Hyperkinesis	7
Disease	7
Cocaine-Related Disorders	2

Clinical Trial Locations for DEXEDRINE

Trials by Country

Trials by Country for DEXEDRINE
Location	Trials
United States	12
Canada	6

Trials by US State

Trials by US State for DEXEDRINE
Location	Trials
Texas	4
Massachusetts	2
California	2
New York	2
Connecticut	1

Clinical Trial Progress for DEXEDRINE

Clinical Trial Phase

Clinical Trial Phase for DEXEDRINE
Clinical Trial Phase	Trials
Phase 4	5
Phase 2	4
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for DEXEDRINE
Clinical Trial Phase	Trials
Unknown status	5
Completed	5
Recruiting	4

Clinical Trial Sponsors for DEXEDRINE

Sponsor Name

Sponsor Name for DEXEDRINE
Sponsor	Trials
The University of Texas Health Science Center, Houston	4
McGill University Health Centre/Research Institute of the McGill University Health Centre	3
Canadian Institutes of Health Research (CIHR)	3

Sponsor Type

Sponsor Type for DEXEDRINE
Sponsor	Trials
Other	27
NIH	2
Industry	1